Further experiments showed that MDMX silencing induces growth arrest, apoptosis and p53 activation in NSCLC cells, similar to that observed with USP22 silencing; and over-expression of MDMX reverses USP22 silencing-induced effects. This evidence concerns the gene TP53 and non-small cell lung carcinoma.